Procter & Gamble Health | PGHL | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in June. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2016
2017
2018
2020
2021
Revenue
Revenue
9,96311,1958,49013,55910,268
Cost of revenue
Cost of revenue
-4,126-4,566-2,694-4,314-3,148
Gross Profit
Gross Profit
5,837
6,629
5,796
9,244
7,120
Sales, general & ad...
Sales, general and administrative
-4,644-5,080-4,323-6,090-4,479
Depreciation
Depreciation and amortization
-276-436-204-295-300
Provision
Provision
-580000
Other op inc/exp...
Other operating income/expenses
00000
Operating income
Operating income EBIT
860
1,112
1,270
2,860
2,341
 
      
Profit before tax
Profit before tax
1,1021,5228,9503,5492,333
Net Income
Net income
759
939
8,387
2,541
1,768
 
 
 
 
 
 
 
EPS Basic
EPS Basic in Rupees
45.72
56.57
505.27
153.07
106.51